Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure.
Hundertmark MJ, Agbaje OF, Coleman R, George JT, Grempler R, Holman RR, Lamlum H, Lee J, Milton JE, Niessen HG, Rider O, Rodgers CT, Valkovič L, Wicks E, Mahmod M, Neubauer S. Hundertmark MJ, et al. Among authors: wicks e. ESC Heart Fail. 2021 Aug;8(4):2580-2590. doi: 10.1002/ehf2.13406. Epub 2021 May 6. ESC Heart Fail. 2021. PMID: 33960149 Free PMC article. Clinical Trial.
Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study.
Raman B, Smillie RW, Mahmod M, Chan K, Ariga R, Nikolaidou C, Ormondroyd E, Thomson K, Harper AR, Tan G, Lewandowski AJ, Rodriguez Bajo F, Wicks EC, Casadei B, Watkins H, Neubauer S. Raman B, et al. Among authors: wicks ec. J Cardiovasc Magn Reson. 2021 Oct 11;23(1):109. doi: 10.1186/s12968-021-00793-6. J Cardiovasc Magn Reson. 2021. PMID: 34635131 Free PMC article.
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
Hundertmark MJ, Adler A, Antoniades C, Coleman R, Griffin JL, Holman RR, Lamlum H, Lee J, Massey D, Miller JJJJ, Milton JE, Monga S, Mózes FE, Nazeer A, Raman B, Rider O, Rodgers CT, Valkovič L, Wicks E, Mahmod M, Neubauer S. Hundertmark MJ, et al. Among authors: wicks e. Circulation. 2023 May 30;147(22):1654-1669. doi: 10.1161/CIRCULATIONAHA.122.062021. Epub 2023 Apr 18. Circulation. 2023. PMID: 37070436 Free PMC article. Clinical Trial.
Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis.
Ashkir Z, Johnson S, Lewandowski AJ, Hess A, Wicks E, Mahmod M, Myerson S, Ebbers T, Watkins H, Neubauer S, Carlhäll CJ, Raman B. Ashkir Z, et al. Among authors: wicks e. Eur Heart J Cardiovasc Imaging. 2023 Aug 23;24(9):1192-1200. doi: 10.1093/ehjci/jead074. Eur Heart J Cardiovasc Imaging. 2023. PMID: 37114738 Free PMC article.
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial.
Foley PW, Kalra PR, Cleland JGF, Petrie MC, Kalra PA, Squire I, Campbell P, Chapman C, Donnelly P, Graham F, Hannah A, Lang NN, Matthews I, Leslie SJ, Pellicori P, Piper S, Ray R, Savage HO, Spencer C, Walsh J, Wong YK, Ford I;  on behalf of the IRONMAN Study Group. Foley PW, et al. Eur J Heart Fail. 2024 Oct 25. doi: 10.1002/ejhf.3504. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39453738
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.
Cleland JGF, Kalra PA, Pellicori P, Graham FJ, Foley PWX, Squire IB, Cowburn PJ, Seed A, Clark AL, Szwejkowski B, Banerjee P, Cooke J, Francis M, Clifford P, Wong A, Petrie C, McMurray JJV, Thomson EA, Wetherall K, Robertson M, Ford I, Kalra PR; IRONMAN Study Group. Cleland JGF, et al. Eur Heart J. 2024 Apr 21;45(16):1410-1426. doi: 10.1093/eurheartj/ehae086. Eur Heart J. 2024. PMID: 38446126 Free PMC article. Clinical Trial.
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction.
Ray R, Ford I, Cleland JGF, Graham F, Ahmed FZ, Al-Mohammad A, Cowburn PJ, Critoph C, Kalra PA, Lane RE, Ludman A, Pellicori P, Petrie MC, Robertson M, Seed A, Squire I, Kalra PR; INVESTIGATORS; CLINICAL TRIALS UNIT AND DATA AND STATISTICAL CENTRE; NURSING AND ADMINISTRATIVE SUPPORT; SPONSOR SUPPORT. Ray R, et al. J Card Fail. 2024 May;30(5):682-690. doi: 10.1016/j.cardfail.2023.10.006. Epub 2023 Nov 4. J Card Fail. 2024. PMID: 37926238 Free PMC article. Clinical Trial.
76 results